← FDA Drug Approvals (Drugs@FDA)

GLYCOPYRROLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT · Approved 2020-02-21

Drug application

FDA Application #

ANDA210083

Application type

Abbreviated New Drug Application (Generic)

Brand name

GLYCOPYRROLATE

Generic name

GLYCOPYRROLATE

Active ingredients

GLYCOPYRROLATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SAGENT

Manufacturer

Sagent Pharmaceuticals

First approval

2020-02-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown